Rapid manufacturing of vaccines for pandemic response & personalized cancer: parallels to leverage for common pathways to expedite clinical development?

“...the paradigm shifts required to substantially condense timelines could come from the field of neoantigen based personalized cancer vaccines.”

Please enter your email to access content Read now